Klimadynon (Dry Extract From Cimicifuga Racemosa (L.) Nutt., Rhizoma (Black Cohosh) (5-10:1), Extraction Solvent)

The extract contains triterpene glycosides and phenolic compounds that act on serotonergic receptors and exhibit weak estrogenic activity. These actions help modulate the hypothalamic pathways that control body temperature and mood, thereby reducing vasomotor symptoms associated with menopause.

The appropriate dose of Klimadynon is determined by the prescribing clinician based on individual health status, severity of symptoms and any concomitant therapies. Patients should follow the specific instructions provided by their health‑care professional.

Klimadynon is generally not recommended for use during pregnancy or while breastfeeding unless a qualified health‑care provider explicitly advises otherwise. Limited safety data are available for these populations, so caution is advised.

To order Klimadynon, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Compared with conventional hormone replacement therapy, Klimadynon offers a non‑hormonal botanical option that may have a different side‑effect profile. It does not contain synthetic hormones, making it an alternative for patients seeking plant‑based support, though efficacy and safety should be evaluated individually.

Klimadynon should be stored at ambient temperature below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid exposure to extreme temperatures.

Klimadynon is administered orally, typically as a capsule or tablet, according to the dosage prescribed by a health‑care professional. It should be taken with water and may be taken with or without food as directed.

The most serious risks include rare cases of liver injury, severe allergic reactions such as anaphylaxis, and, very rarely, severe skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice signs of liver dysfunction, rash, swelling or breathing difficulties.

Individuals with known hypersensitivity to black cohosh, those with active liver disease, pregnant or breastfeeding women (unless advised by a clinician), and patients taking medications that have major interactions—such as estrogen‑based hormone therapy or anticoagulants—should avoid using Klimadynon unless cleared by a health‑care professional.